Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai, Maharashtra, India.
| FactSnippet No. 1,001,465 |
17 Facts About Lupin Limited
2.
Lupin Limited's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
| FactSnippet No. 1,001,466 |
3.
Lupin Limited was founded in 1968 by Desh Bandhu Gupta, who was a professor of chemistry at BITS-Pilani, Rajasthan.
| FactSnippet No. 1,001,467 |
4.
In October 2019, Lupin Limited announced the Appointment of Sreeji Gopinatham as Chief Information Officer .
| FactSnippet No. 1,001,468 |
5.
Lupin Limited's businesses encompass the entire pharmaceutical value chain, ranging from branded and generic formulations, APIs, advanced drug delivery systems to biotechnology.
| FactSnippet No. 1,001,469 |
6.
Lupin Limited's drugs reach 70 countries with a footprint that covers advanced markets such as USA, Europe, Japan, Australia as well as emerging markets including India, the Philippines and South Africa to name a few.
| FactSnippet No. 1,001,470 |
7.
Lupin Limited is the market leader in 28 products out of the 77 products marketed in the US generics market, of which it is amongst the Top 3 by market share in 57 of these products : Suprax, a paediatric antibiotic, is Lupin's top-selling product here.
| FactSnippet No. 1,001,471 |
8.
Lupin Limited's focus in the European Union encompasses Anti-Infectives, Cardiovascular, and CNS therapy areas, along with niche opportunities in segments like Oral Contraceptives, Dermatology and Ophthalmics.
| FactSnippet No. 1,001,472 |
9.
Lupin Limited is the fastest-growing Top 10 generic pharmaceuticals player in Japan .
| FactSnippet No. 1,001,473 |
10.
In 2014, Lupin Limited entered into a strategic joint venture agreement with Toyama-based Japanese pharmaceuticals company, Yoshindo Inc to create YL Biologics .
| FactSnippet No. 1,001,474 |
11.
Lupin Limited is a market leader in the Cardiovascular segment and has a growing presence in Neurology, Gastroenterology and the Over the Counter segments.
| FactSnippet No. 1,001,475 |
12.
Lupin Limited entered the Australian market through its subsidiary, Generic Health Pte.
| FactSnippet No. 1,001,476 |
13.
Lupin Limited's Philippines subsidiary Multicare Pharmaceuticals, is a branded generic company focused on Women's Health, Pediatrics, Gastro-Intestinal and Diabetes care.
| FactSnippet No. 1,001,477 |
14.
Lupin Limited is a global leader in Cephalosporins, Cardiovasculars and the anti-TB space.
| FactSnippet No. 1,001,478 |
15.
Lupin Limited is a strategic supplier of anti-TB products to the Stop TB Partnership, with its formulations supplied to more than 50 countries through GDF procurement.
| FactSnippet No. 1,001,479 |
16.
Lupin Limited forayed into diagnostics business in December 2021 to provide a comprehensive range of diagnostic tests in India which includes molecular diagnostics, cytogenetics, flow cytometry, microbiology and serology among others.
| FactSnippet No. 1,001,480 |
17.
In July 2018, Lupin Limited foundation signed a statement of Intent with the National Institution for Transforming India, a policy think tank of the government of India, to collaborate in the Aspirational Districts Programme and support the development of three backward districts – Nandurbar in Maharashtra, Vidisha in Madhya Pradesh and Dholpur in Rajasthan.
| FactSnippet No. 1,001,481 |